BSE Live
Mar 14, 16:00Prev. Close
396.55
Open Price
395.10
Bid Price (Qty.)
395.00 (1000)
Offer Price (Qty.)
396.55 (187)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Claris Lifesciences (in Rs. Cr.) | Mar 17 | Mar 16 | Mar 15 | Dec 13 | Dec 12 | |
| 12 mths | 12 mths | 15 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 162.47 | 100.34 | 144.47 | 107.49 | 135.78 | |
| Net CashFlow From Operating Activities | 179.35 | 138.53 | -44.26 | 143.38 | 334.18 | |
| Net Cash Used In Investing Activities | -58.46 | -40.30 | -120.02 | 197.01 | -436.61 | |
| Net Cash Used From Financing Activities | -105.49 | 26.17 | 152.21 | -342.88 | 58.27 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 15.41 | 124.40 | -12.07 | -2.49 | -44.16 | |
| Cash And Cash Equivalents Begin of Year | 137.09 | 61.73 | 73.79 | 76.28 | 120.44 | |
| Cash And Cash Equivalents End Of Year | 152.50 | 186.13 | 61.73 | 73.79 | 76.28 |
03.12.2017
17.10.2017
31.07.2017
US FDA conducts surprise audit at Claris Life's Ahmedabad unit
27.07.2017
Claris completes injectables biz sale, to inform about transfer to shareholders by Oct
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth